{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:17:35Z","timestamp":1776889055368,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Selection criteria and prognostic factors for patients with advanced gastric cancer (AGC) undergoing cytoreductive surgery (CRS) plus hyperthermic intra-operative peritoneal chemotherapy (HIPEC) have not been well defined, and the literature data are not homogeneous. The aim of this study was to compare prognostic factors influencing overall (OS) and disease-free survival (DFS) in a population of patients affected by AGC with surgery alone and surgery plus HIPEC, both with curative (PCI, peritoneal carcinomatosis index <jats:underline>&gt;<\/jats:underline> 1) and prophylactic (PCI = 0) intent.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of a prospectively collected database was conducted in patients affected by AGC from January 2006 to December 2015. Uni- and multivariate analyses of prognostic factors were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 85 patients with AGC were analyzed. A 5-year OS for surgery alone, CRS plus curative HIPEC, and surgery plus prophylactic HIPEC groups was 9%, 27% and 33%, respectively. Statistical significance was reached comparing both prophylactic HIPEC vs surgery alone group (<jats:italic>p<\/jats:italic> = 0.05), curative HIPEC vs surgery alone group (<jats:italic>p<\/jats:italic> = 0.03), and curative vs prophylactic HIPEC (<jats:italic>p<\/jats:italic> = 0.04). A 5-year DFS for surgery alone, CRS + curative HIPEC, and surgery + prophylactic HIPEC groups was 9%, 20%, and 30%, respectively. Statistical significance was reached comparing both prophylactic HIPEC vs surgery alone group (<jats:italic>p<\/jats:italic> &lt; 0.0001), curative HIPEC vs surgery alone group (<jats:italic>p<\/jats:italic> = 0.008), and curative vs prophylactic HIPEC (<jats:italic>p<\/jats:italic> = 0.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with AGC undergoing surgery plus HIPEC had a better OS and DFS with respect to patients treated with surgery alone.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00423-021-02102-2","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T08:03:23Z","timestamp":1615449803000},"page":"1847-1857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center"],"prefix":"10.1007","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-8354","authenticated-orcid":false,"given":"Fausto","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Galiandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Di Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Pio","family":"Tortorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"2102_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2102_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000012086","volume":"58","author":"PH Sugarbaker","year":"2000","unstructured":"Sugarbaker PH, Yonemura Y (2000) Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58:96\u2013107","journal-title":"Oncology"},{"key":"2102_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecological malignancy. A prospective study of prognostic factors. Cancer 63:364\u2013367","journal-title":"Cancer"},{"key":"2102_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236\u2013242","journal-title":"Br J Surg"},{"key":"2102_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Fran\u00e7ois Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE I multicentric prospective study. Cancer 88:358\u2013363","journal-title":"Cancer"},{"key":"2102_CR6","doi-asserted-by":"publisher","unstructured":"Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J et al (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 17(3):CD004064. https:\/\/doi.org\/10.1002\/14651858.CD004064.pub3","DOI":"10.1002\/14651858.CD004064.pub3"},{"key":"2102_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29\u201342","journal-title":"Ann Surg"},{"key":"2102_CR8","first-page":"124","volume":"41","author":"FN Gilly","year":"1994","unstructured":"Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B, Bienvenu J, Burgard G, Guibert B, Banssillon V (1994) Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124\u2013129","journal-title":"Hepatogastroenterology"},{"key":"2102_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C","volume":"79","author":"S Fujimoto","year":"1997","unstructured":"Fujimoto S, Takahaschi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E et al (1997) Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79:884\u2013891","journal-title":"Cancer"},{"key":"2102_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF00299188","volume":"19","author":"Y Yonemura","year":"1995","unstructured":"Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Sawa T et al (1995) Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 19:450\u2013455","journal-title":"World J Surg"},{"key":"2102_CR11","first-page":"1","volume":"12","author":"R Dedrick","year":"1985","unstructured":"Dedrick R (1985) Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 12:1\u20136","journal-title":"Semin Oncol"},{"key":"2102_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1211\/0022357055380","volume":"57","author":"T Shimada","year":"2005","unstructured":"Shimada T, Nomura M, Yokogawa K, Endo Y, Sasaki T, Miyamoto K, Yonemura Y (2005) Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice. J Pharm Pharmacol 57:177\u2013181","journal-title":"J Pharm Pharmacol"},{"key":"2102_CR13","first-page":"1916","volume":"41","author":"JL Speyer","year":"1981","unstructured":"Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW Jr, Myers CE (1981) Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 41:1916\u20131922","journal-title":"Cancer Res"},{"key":"2102_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/0360-3016(90)90344-J","volume":"19","author":"J Laundry","year":"1990","unstructured":"Laundry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J (1990) Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 19:1357\u20131362","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2102_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-7819-7-5","volume":"7","author":"G Glockzin","year":"2009","unstructured":"Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5","journal-title":"World J Surg Oncol"},{"key":"2102_CR16","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1245\/s10434-007-9487-4","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL (2007) A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14:2702\u20132713","journal-title":"Ann Surg Oncol"},{"key":"2102_CR17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3748\/wjg.v22.i3.1114","volume":"22","author":"RA Seshadri","year":"2016","unstructured":"Seshadri RA, Glehen O (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 22:1114\u20131130","journal-title":"World J Gastroenterol"},{"key":"2102_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric cancer carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31\u201349","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2102_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. Ca - Cancer J Clin. 67:93\u201399","journal-title":"Ca - Cancer J Clin."},{"key":"2102_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","volume":"18","author":"B O'Sullivan","year":"2017","unstructured":"O'Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, Pi\u00f1eros M, van Eycken E, Weir HK, Gospodarowicz M (2017) The TNM classification of malignant tumours-towards common understanding and reasonable expectations. Lancet Oncol 18:849\u2013851","journal-title":"Lancet Oncol"},{"key":"2102_CR21","doi-asserted-by":"publisher","unstructured":"(2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101\u2013112. https:\/\/doi.org\/10.1007\/s10120-011-0041-5","DOI":"10.1007\/s10120-011-0041-5"},{"key":"2102_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH (1999) Management of peritoneal-surface malignancy: the surgeon\u2019s role. Langenbeck\u2019s Arch Surg 384:576\u2013587","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"2102_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 240:205\u2013213","journal-title":"Ann Surg."},{"key":"2102_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11\u201320","journal-title":"N Engl J Med"},{"issue":"12","key":"2102_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1477-7819-12-217","volume":"16","author":"F Rosa","year":"2014","unstructured":"Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB (2014) Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years. World J Surg Oncol 16(12):217","journal-title":"World J Surg Oncol"},{"key":"2102_CR26","first-page":"2005","volume":"21","author":"GL Baiocchi","year":"2014","unstructured":"Baiocchi GL, Marrelli D, Verlato G, Morgagni P, Giacopuzzi S, Coniglio A, Marchet A, Rosa F, Capponi MG, di Leo A, Saragoni L, Ansaloni L, Pacelli F, Nitti D, D'Ugo D, Roviello F, Tiberio GA, Giulini SM, de Manzoni G (2014) Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer. Ann Surg Oncol 21:2005\u20132011","journal-title":"Ann Surg Oncol"},{"key":"2102_CR27","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11605-012-2059-3","volume":"16","author":"M Imano","year":"2012","unstructured":"Imano M, Yasuda A, Itoh T, Satou T, Peng YF, Kato H, Shinkai M, Tsubaki M, Chiba Y, Yasuda T, Imamoto H, Nishida S, Takeyama Y, Okuno K, Furukawa H, Shiozaki H (2012) Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. J Gastrointest Surg 16:2190\u20132196","journal-title":"J Gastrointest Surg"},{"key":"2102_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/02656736.2013.768359","volume":"29","author":"DH Mi","year":"2013","unstructured":"Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, Santesso N, Ma B, Chen YL, Liu YL (2013) Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Int J Hyperthermia 29:156\u2013167","journal-title":"Int J Hyperthermia"},{"key":"2102_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","volume":"2","author":"S Gonz\u00e1lez-Moreno","year":"2010","unstructured":"Gonz\u00e1lez-Moreno S, Gonz\u00e1lez-Bay\u00f3n LA, Ortega-P\u00e9rez G (2010) Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol 2:68\u201375","journal-title":"World J Gastrointest Oncol"},{"key":"2102_CR30","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ejso.2007.12.003","volume":"34","author":"S Scaringi","year":"2008","unstructured":"Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S (2008) Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. European Journal of Surgical Oncology 34:1246\u20131252","journal-title":"European Journal of Surgical Oncology"},{"key":"2102_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T (1988) Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61:232\u2013237","journal-title":"Cancer"},{"key":"2102_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00000658-199011000-00005","volume":"212","author":"S Fujimoto","year":"1990","unstructured":"Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C et al (1990) Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 212:592\u2013596","journal-title":"Ann Surg"},{"key":"2102_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ssu.10042","volume":"21","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21:233\u2013248","journal-title":"Semin Surg Oncol"},{"key":"2102_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/1471-2407-12-526","volume":"12","author":"J Sun","year":"2012","unstructured":"Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, Liang J, Xu H (2012) Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 12:526","journal-title":"BMC Cancer"},{"key":"2102_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G, Piaton E, Garofalo A (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14:183","journal-title":"BMC Cancer"},{"key":"2102_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, Parisi A, Woo Y (2017) The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 79:1\u201314","journal-title":"Eur J Cancer"},{"issue":"6","key":"2102_CR37","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6):1575\u20131581","journal-title":"Ann Surg Oncol"},{"key":"2102_CR38","first-page":"1375","volume":"19","author":"AC Sayag-Beaujard","year":"1999","unstructured":"Sayag-Beaujard AC, Francois Y, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Panteix G, Garbit F, Grandcl\u00e9ment E, Vignal J, Gilly FN (1999) Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 19:1375\u20131382","journal-title":"Anticancer Res"},{"key":"2102_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/bjs.4695","volume":"92","author":"Y Yonemura","year":"2005","unstructured":"Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370\u2013375","journal-title":"Br J Surg"},{"issue":"23","key":"2102_CR40","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Gagni\u00e8re J, Lefevre JH, Courvoisier T, Kianmanesh R, Vaudoyer D, Rivoire M, Meeus P, Passot G, Glehen O, on behalf of the FREGAT and BIG-RENAPE Networks (2019 Aug 10) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 37(23):2028\u20132040","journal-title":"J Clin Oncol."}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-021-02102-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T05:09:07Z","timestamp":1632892147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-021-02102-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1007\/s00423-021-02102-2","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}